|
PPFIBP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.590140E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.6359999950063E-08 |
| Normal-vs-Stage2 |
2.132000E-02 |
| Normal-vs-Stage3 |
2.070600E-01 |
| Normal-vs-Stage4 |
5.336000E-01 |
| Stage1-vs-Stage2 |
5.731200E-01 |
| Stage1-vs-Stage3 |
2.991600E-04 |
| Stage1-vs-Stage4 |
4.97669999655059E-08 |
| Stage2-vs-Stage3 |
1.284380E-01 |
| Stage2-vs-Stage4 |
9.745000E-03 |
| Stage3-vs-Stage4 |
9.192400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.012900E-04 |
| Normal-vs-AfricanAmerican |
2.385900E-02 |
| Normal-vs-Asian |
4.134200E-02 |
| Caucasian-vs-AfricanAmerican |
7.513000E-01 |
| Caucasian-vs-Asian |
3.411900E-02 |
| AfricanAmerican-vs-Asian |
6.814300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.656800E-03 |
| Normal-vs-Female |
2.48509999999369E-05 |
| Male-vs-Female |
1.157400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.729760E-01 |
| Normal-vs-Age(41-60Yrs) |
1.77660999999274E-05 |
| Normal-vs-Age(61-80Yrs) |
7.915700E-03 |
| Normal-vs-Age(81-100Yrs) |
9.340200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.196800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.407800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.147400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.810300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.226400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.417600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.71170000021704E-07 |
| Normal-vs-Grade 2 |
1.81310000346713E-08 |
| Normal-vs-Grade 3 |
7.459500E-03 |
| Normal-vs-Grade 4 |
2.289600E-02 |
| Grade 1-vs-Grade 2 |
1.224830E-01 |
| Grade 1-vs-Grade 3 |
5.676400E-03 |
| Grade 1-vs-Grade 4 |
9.37030000258687E-08 |
| Grade 2-vs-Grade 3 |
1.621310E-03 |
| Grade 2-vs-Grade 4 |
9.46576150795408E-13 |
| Grade 3-vs-Grade 4 |
1.41490000005184E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.42794673255275E-12 |
| Normal-vs-ccB subtype |
8.568800E-01 |
| ccA subtype-vs-ccB subtype |
2.18158824338843E-13 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.207700E-04 |
| Normal-vs-N1 |
7.331400E-01 |
| N0-vs-N1 |
9.980000E-02 |
|
|
